The Medical Device Regulation & COVID-19
The merger with Arbour Group, LLC will enable PharmaLex to strengthen its existing compliance solutions and expand into new territories
Frankfurt, Germany – 5 February 2020: PharmaLex Group, one of the most experienced and most successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, have completed the merger of Arbour Group, LLC in the US.
Arbour Group is a leading global provider of regulatory compliance solutions for the life sciences industry. Headquartered in Chicago, Illinois, Arbour Group has offices throughout North America along with service delivery centers in Dubai, UAE and Manila, Philippines.
The addition of Arbour Group will reinforce the existing quality management and compliance portfolio of PharmaLex with expertise in the field of IT Systems Validation and Compliance. This also supports a key focus of delivering Connected Health solutions to help customers address industry advances in Artificial Intelligence, Cloud Applications and GDPR. In addition to strengthening its foothold in the US, the merger will provide PharmaLex the opportunity to expand its global reach and take advantage of the off-shoring capabilities afforded by the Dubai and Manila operations.
“Arbour Group and PharmaLex have a shared commitment to provide reputable solutions with exceptional results that will not only favor our partnership but will also benefit our customers with noteworthy regulatory expertise,” noted Ahsan Raza, President of Arbour Group.
“Arbour Group is a well-recognized service provider with an excellent reputation in the regulatory compliance market,” explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Their specialist expertise will enable us to drive business in the US whilst allowing us to expand our quality management and compliance service line worldwide,” he added.
-Ends-
About PharmaLex <Confidence beyond compliance>:
PharmaLex is one of the largest providers of specialist services for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology and Risk Management worldwide. Our global teams of experts can take you through early strategic planning activities and non-clinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities. We strive to deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions. We aim to exceed your expectations and live by our values – flexibility, efficiency, passion and dedication.
The PharmaLex Group now has over 1000 employees, with 33 offices in 21 countries and more than 600 satisfied clients worldwide.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director, Business Development Operations
eva.keck@pharmalex.com
+49 621 18 15 38 0
Harrlachweg 6
68163 Mannheim
Germany
Related posts
